Antigen test kit - Import export

The SARSCoV2 Antigen Rapid Test Kit is a colloidal gold enhanced double antibody san dwich immunoassay for the qualitative determination of SARSCoV2 antigen.The test region (T) of nitrocellulose membrane was immobilized with mouse anti SARSCoV2 antibody 1 (Ab1), and the control region (C) was immobilized with Goat anti chicken IgY antibody (GAC). At the same time, the binding pad of the test card was fixed with mouse anti SARSCoV2 antibody 2 (Ab2) a nd chicken IgY (CIgY) which were both labeled by colloidal gold.

This SARS-CoV-2 & Flu A+B Antigen Combo Rapid Test Kit is only used for rapid in vitroqualitative detection of SARS-CoV-2, influenza A and influenza B nucleoprotcin antigens innasopharyngeal swab, nasal swab, oropharyngeal swab or saliva specimens. It is intended toaid in the rapid differential diagnosis of SARS-CoV-2, influenza A and influenza B viral infections. Negative test results do not preclude SARS-CoV-2 or influenza infections andshould not be used as the sole basis for treatment or other patient management decisions.

The Covid-19 Antigen Rapid Test Casserre is a lateral flow immunoassay intended fort he qualitative detection Sars-Cov-2 nucleocapsid antigens in nasophartngeal swab and orosharyngeal wsab from individuals wha are suspected of COVID-19 by their healtcare provider.

Rapid antigen test COVID-19 swab test LIFECOSM - 25 pieces - SARS-CoV-2 to the extended 4in1 successor article most sensitive rapid corona test in Germany according to the Paul Ehrlich Institute (PEI) listed at the BfArM 100% overall sensitivity according to PEI -> AT1054/21 | AT 1055/21 | AT1056/21 | AT1340/21 | AT1361/21 -> same test cassette detects current virus mutations, reliable at Omikron reimbursable by test regulation

The TÜV-certified CLUNGSE COVID-19 antigen test is a rapid test for the qualitative detection of nucleocapsid protein antigens in nasal or nasopharyngeal swabs. The SARS-CoV-2 test listed by the BfArM may be carried out either by medical professionals or by appropriately trained professionals. The 3in1 antigen test is characterized by new batches that recognize Omikron with high specificity and are optimized for professional use. The tests are prefilled, the buffer solution bottle is sealed for error-free handling and the sample can be taken via the following swabs: nasal, oropharyngeal and nasopharyngeal. Thanks to the high sensitivity and specificity, the test result is particularly reliable. The test can already be read after 10 - 15 minutes. • 3in1 antigen test according to the Federal Institute for Drugs and Medical Devices approval AT079/20 • Format - Immunoassay​ • Sampling Nasopharyngeal swab and/or nasal • Packaging 25 tests per case

Easy handling thanks to minimally invasive sampling as a nasal swab (2.5 cm depth) Also very good for use with small children, students, handicapped people, professional sports activities and in companies This test is Made in Germany and approved for use by laypersons Reliable with 100% sensitivity and 98% specificity

With the self/rapid test you get a high-quality corona antigen self-test, which is used for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in the front nasal cavity in a short time. It is based on the lateral flow immunoassay method, which uses antibodies to detect specific antigens in the sample swab.

The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection test includes a Primer-Probe set inside the Reaction Mix that contains primers and probes for human RNaseP and viral N1 and N2 regions. The internal control (primer/probe set for human RNaseP gene) is used to identify possible qPCR inhibition, confirm the integrity of the reagents, and verify the quality of RNA extraction from patient material. RNaseP primers and probes included in the kit recognize the human RNaseP gene. The primers and probes for viral N1 and N2 regions specifically identify two distinct regions on the nucleocapsid (N) gene of the SARS-CoV-2 virus. These primers and probes do not recognize the SARS-CoV virus, whose genetic structure is highly similar to SARS-CoV-2.